Litigation Details for UCB Inc. v. Watson Laboratories Inc. (NV) (D. Del. 2014)
✉ Email this page to a colleague
UCB Inc. v. Watson Laboratories Inc. (NV) (D. Del. 2014)
| Docket | ⤷ Try a Trial | Date Filed | 2014-08-21 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Sue Lewis Robinson |
| Jury Demand | None | Referred To | Judge Sherry R. Fallon |
| Patents | 6,699,498; 6,884,434; 7,413,747; 8,246,979; 8,246,980; 8,617,591 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in UCB Inc. v. Watson Laboratories Inc. (NV)
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for UCB Inc. v. Watson Laboratories Inc. (NV) (D. Del. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-11-09 | 111 | APPENDIX A Agreed Upon Claim Term of U.S. Patent No. 6,884,434 Claim Term …constructions of the agreed upon and disputed terms of the Patents- in-Suit are attached hereto as Appendices A-D… APPENDIX B Agreed Upon Claim Terms of U.S. Patent No. 7,413,747 Claim Term … APPENDIX C Agreed Upon Claim Term of U.S. Patent No. 8,617,591 Claim Term … adhesive matrix” Disputed Claim Term of U.S. Patent No. 8,617,591 Claim Term | External link to document | |
| 2016-01-08 | 120 | disputed claim language of U.S. Patent No. 8,617,591 (“the '591 patent") shall be construed consistent….” (4:42-47) 2. During prosecution of the ‘591 patent, the applicant argued that claim 8 (which later… August 2014 1:14-cv-01083-LPS-SRF Patent None District Court, D. Delaware | External link to document | |
| 2014-08-21 | 3 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,699,498; 6,884,434; 7,413,747… August 2014 1:14-cv-01083-LPS-SRF Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
